ES550089A0 - Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. - Google Patents

Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Info

Publication number
ES550089A0
ES550089A0 ES550089A ES550089A ES550089A0 ES 550089 A0 ES550089 A0 ES 550089A0 ES 550089 A ES550089 A ES 550089A ES 550089 A ES550089 A ES 550089A ES 550089 A0 ES550089 A0 ES 550089A0
Authority
ES
Spain
Prior art keywords
coadjuvated
viruses
bacteria
proteins
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES550089A
Other languages
English (en)
Other versions
ES8801583A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES550089A0 publication Critical patent/ES550089A0/es
Publication of ES8801583A1 publication Critical patent/ES8801583A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES550089A 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. Expired ES8801583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843446515 DE3446515A1 (de) 1984-12-20 1984-12-20 Oeladjuvierte vaccine und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES550089A0 true ES550089A0 (es) 1988-02-16
ES8801583A1 ES8801583A1 (es) 1988-02-16

Family

ID=6253325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550089A Expired ES8801583A1 (es) 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Country Status (8)

Country Link
EP (1) EP0187286A1 (es)
DE (1) DE3446515A1 (es)
DK (1) DK593985A (es)
ES (1) ES8801583A1 (es)
FI (1) FI855057L (es)
GR (1) GR853058B (es)
NO (1) NO855169L (es)
PT (1) PT81713B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DE3817531A1 (de) * 1988-05-24 1989-12-07 Behringwerke Ag Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
CA2654522C (en) * 1997-08-29 2014-01-28 Antigenics Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL269002A (es) * 1960-09-06
GB1083815A (en) * 1963-10-01 1967-09-20 Wellcome Found Vaccine adjuvants
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
DE3261734D1 (en) * 1981-03-03 1985-02-14 Centraal Diergeneeskundig Inst Water-in-oil emulsion for use in the potentation of the immune system of animals
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen

Also Published As

Publication number Publication date
FI855057A7 (fi) 1986-06-21
FI855057A0 (fi) 1985-12-18
PT81713B (de) 1987-08-10
PT81713A (de) 1986-01-01
FI855057L (fi) 1986-06-21
GR853058B (es) 1986-04-15
DK593985A (da) 1986-06-21
DE3446515A1 (de) 1986-06-26
NO855169L (no) 1986-06-23
ES8801583A1 (es) 1988-02-16
DK593985D0 (da) 1985-12-19
EP0187286A1 (de) 1986-07-16

Similar Documents

Publication Publication Date Title
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
EP0149040A3 (en) Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
EP0179139A4 (en) ANALYSIS, VACCINE AND IMMUNOGEN OF THE VIRUS ASSOCIATED WITH LEUKEMIA.
ES552169A0 (es) Un metodo para tratar termicamente, inactivando virus, a una solucion acuosa de gamma-globulina
FI831234A7 (fi) Uudet välituotteet, niiden valmistusmenetelmä ja niiden käyttö.
FI823021A7 (fi) Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
ES521411A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus.
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
ES519551A0 (es) Nuevas vacunas contra la bronquitis infecciosa.
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
ATE16454T1 (de) Influenzavirus-vaccine, verfahren zu ihrer herstellung und verfahren zur vermehrung von influenzaviren.
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
ES527588A0 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
ES500199A0 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
FI811685A7 (fi) Menetelmä virusperäisten glykoproteiiniantigeenien eristämiseksi ja niiden käyttö rokotteiden vvalmistukseen.
FI793375A7 (fi) Antikoagulantti, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset valmisteet.
FI922851A7 (fi) Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
EP0236487A4 (en) Virus inactivation.
FI841094A7 (fi) Kantajaan sidottu virusantigeeni, sen valmistus ja käyttö.
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
EP0198828A4 (en) VACCINE AGAINST THE VIRUSES OF INFECTIOUS BURSAL DISEASE.